NEXT PREV

Maximize US & Global Pricing and Market Access for your novel launch asset or for your successful inline drug

scroll to explore 01. Innovative Solutions Previous Contact Us Next 03. .

15+

New Drug Launches Supported
NEXT PREV

Optimize US & Global Payer and HTA Agency Engagements for your novel launch asset or your re-assessed inline drug

02. Smart Strategies scroll to explore Previous Contact Us Next 03. .

15+

New Drug Launches Supported
NEXT PREV

Refine the US & Global Opportunity Forecast and GTM Strategy for your launch asset or for your inline drug

03. Visions into Reality Previous contact us scroll to explore Next 03. .

15+

New Drug Launches Supported

Top Quality

Based on several decades of experience at leading consultancies, we guarantee expertise and work of equal, and usually better, quality vs. "better-known" competitors
01.

Top Speed

With our lean staffing model and highly experienced team, we guarantee faster project delivery by up to 2 weeks vs. the “fastest” competitor w/o impact on quality
02.

Top Pricing

Due to much more efficient firm management and limited overhead, we guarantee transparent prices at an up to 10% discount vs. our “most price-efficient” competitor
03.
About Us

Experience & Expertise: Our Differentiated US & Global Approach

main-about-img

Differentiated Market Research

We are experts in all time-tested primary market research approaches in the pricing and market access space and pair them with our own 100% proprietary market environment-based method for optimal results

Successful Track Record

We collectively finished 150+ projects across 4 continents – Americas, Europe, Asia – since 2009 including market launches of several category-leading products with $10Bn+ in annual worldwide sales

Broad & Wide Experience

We collectively have several decades of hands-on experience in the US and Global pricing and market access space involving the top 10 therapeutic areas by spending and all novel modalities from pills to cell therapies
Our Services

Comprehensive New Drug Launch Strategy & Lifecycle Management Support

Pipeline Optimization

Initial pricing and access environment and clinical trial protocol / strategy reviews to optimally inform pipeline “Go / No Go” decisions
01

Go-To-Market Preparation

Pivotal trial protocol optimization and post-launch competitive environment assessment to fine-tune market launch preparations
02

Launch Maximization

Payer and HTA approach and negotiation strategy optimization and negotiation support tool development to maximize negotiation outcomes
03

Lifecycle Management

Ongoing indication expansion potential assessment and reimbursement model fine-tuning to maximize lifecycle performance through LoE
04
Engagement Models

Flexible, Client-Oriented Ways Of Collaboration At Any Product Development Stage

01

Introductory Project

Ideal relationship “starter” collaboration model allowing Emine to prove ourselves to you as a new client and to identify our ideal collaboration model for future / follow-on engagements
02

Multi-Workstream Engagement

Optimal collaboration structure for a longer-term relationship involving multiple workstreams focused on a single goal – for example, a US pricing assessment + revenue forecasting + payer negotiation support for a new drug launch
03

Ongoing Retainer Partnership

Best suited collaboration model for long-term relationships involving frequent ad-hoc research questions at a pre-agreed fixed monthly budget without any “hour caps” and not on a “penny-pinching” hourly basis

4.9

Client Success: Our #1 Priority - Always!

Success Stories

Maximizing Engagement Outcomes With Our Valued Clients

Send us a Message